Antimicrobial biocompatible bioscaffolds for orthopaedic implants.
Nationally, nearly 1.5 million patients in the USA suffer from ailments requiring bone grafts and hip and other joint replacements. Infections following internal fixation in orthopaedic trauma can cause osteomyelitis in 22-66% of cases and, if uncontrolled, the mortality rate can be as high as 2%. We characterize a procedure for the synthesis of antimicrobial and biocompatible poly-l-lactic acid (PLLA) and poly-ethyleneglycol (PEG) bioscaffolds designed to degrade and absorb at a controlled rate. The bioscaffold architecture aims to provide a suitable substrate for the controlled release of silver nanoparticles (SNPs) to reduce bacterial growth and to aid the proliferation of human adipose-derived stem cells (hASCs) for tissue-engineering applications. The fabricated bioscaffolds were characterized by scanning transmission microscope (SEM) and it showed that the addition of tncreasing concentrations of SNPs results in the formation of dendritic porous channels perpendicular to the axis of precipitation. The antimicrobial properties of these porous bioscaffolds were tested according to a modified ISO 22196 standard across varying concentrations of biomass-mediated SNPs to determine an efficacious antimicrobial concentration. The bioscaffolds reduced the Staphylococcus aureus and Escherichia coli viable colony-forming units by 98.85% and 99.9%, respectively, at an antimicrobial SNPs concentration of 2000 ppm. Human ASCs were seeded on bioscaffolds and cultured in vitro for 20 days to study the effect of SNPs concentration on the viability of cells. SEM analysis and the metabolic activity-based fluorescent dye, AlamarBlue®, demonstrated the growth of cells on the efficacious antimicrobial bioscaffolds. The biocompatibility of in vitro leached silver, quantified by inductively coupled plasma optical emission spectroscopy (ICP-OES), proved non-cytotoxic when tested against hASCs, as evaluated by MTT assay.
Department of Agricultural and Biological Engineering, Louisiana State University and Agricultural Center, Baton Rouge, LA, USA.
Ammar T
AT
Qureshi
Lekeith
L
Terrell
W Todd
WT
Monroe
Vinod
V
Dasa
Marlene E
ME
Janes
Jeffrey M
JM
Gimble
Daniel J
DJ
Hayes
D000273:Adipose Tissue / Q000166:cytology; D000890:Anti-Infective Agents / Q000494:pharmacology*; D001672:Biocompatible Materials / Q000494:pharmacology*; D016923:Cell Death / Q000187:drug effects; D019245:Compressive Strength / Q000187:drug effects; D055119:Elastic Modulus / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D006801:Humans; D019344:Lactic Acid / Q000494:pharmacology; D053768:Metal Nanoparticles / Q000648:ultrastructure; D008826:Microbial Sensitivity Tests; D009985:Orthopedics; D011091:Polyesters; D011092:Polyethylene Glycols / Q000494:pharmacology; D011108:Polymers / Q000494:pharmacology; D019736:Prostheses and Implants; D012834:Silver / Q000494:pharmacology; D013211:Staphylococcus aureus / Q000187:drug effects; D013234:Stem Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D054457:Tissue Scaffolds / Q000737:chemistry*
D000890:Anti-Infective Agents; D001672:Biocompatible Materials; D011091:Polyesters; D011108:Polymers; D019344:Lactic Acid; D012834:Silver; D011092:Polyethylene Glycols; C033616:poly(lactide)